+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cells Market by Cell Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells), Cell Source (Allogeneic, Autologous), Technology, Cell Source, Application, End User - Global Forecast 2025-2030- Product Image
Stem Cells Market by Cell Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells), Cell Source (Allogeneic, Autologous), Technology, Cell Source, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Stem Cells Market by Cell Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells), Cell Source (Allogeneic, Autologous), Technology, Cell Source, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082652
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The stem cells market is undergoing rapid transformation as advancements in cellular biology, engineering, and clinical practice drive new healthcare solutions. Senior decision-makers face a landscape shaped by evolving technologies, dynamic regulations, and global collaborations that are continually redefining possibilities in regenerative medicine and therapy development.

Market Snapshot: Stem Cells Market Growth & Dynamics

The stem cells market grew from USD 14.22 billion in 2024 to USD 15.72 billion in 2025. It is expected to continue growing at a CAGR of 10.89%, reaching USD 26.45 billion by 2030. This sustained acceleration is fueled by mounting investments in research, expanding application areas, and robust global partnerships. As market players increasingly integrate interdisciplinary approaches, the sector is positioned for consistent growth, supported by regulatory agencies adapting to the emerging pace of innovation. Senior executives should monitor shifting priorities, as the competitive landscape continues to evolve with new entrants and established firms refining their portfolios.

Scope & Segmentation of the Stem Cells Market

This report delivers a comprehensive analysis of the evolving stem cells landscape, exploring key market segments, leading technologies, and geographic regions by the following criteria:

  • Cell Types: Adult stem cells, human embryonic stem cells, induced pluripotent stem cells
  • Cell Sources: Allogeneic, autologous, adipose tissue, amniotic cells, bone marrow, peripheral blood, umbilical cord
  • Technologies: Bioprinting, cell culture (2D and 3D), gene editing (CRISPR, transcription activator-like effector nucleases)
  • Applications: Cell banking (private and public), drug discovery and testing (pharmaceutical screening, toxicity testing), regenerative medicine (cardiovascular, neurology, orthopaedics), research and development
  • End Users: Biopharmaceutical companies, contract research organizations, hospitals and clinics, research institutes
  • Geographies: Americas, Europe, Middle East, Africa, and Asia-Pacific, including major countries and regions such as the United States, Canada, Germany, China, Japan, and more
  • Company Coverage: In-depth review of organizations including Danaher Corporation, Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, and others

Key Takeaways for Decision Makers

  • Gene editing, next-generation bioprinting, and advanced cell culture systems are streamlining the path from research to clinical translation, enabling targeted and efficient therapy development.
  • Collaborations across academic, clinical, and industrial stakeholders drive accelerated innovation, while integration of digital technologies enhances analytics, traceability, and supply chain management.
  • Strategic alliances, licensing agreements, and geographic expansion are emerging as preferred pathways to scale manufacturing and access diverse markets.
  • Segment differentiation, such as the use of allogeneic versus autologous cell sources, helps companies address clinical needs and regulatory considerations across various end-user profiles.
  • Emerging global hubs—including Asia-Pacific initiatives and cross-border programs in Europe and the Middle East—are expanding infrastructure and shortening innovation lead times.

Tariff Impact: Navigating the Evolving U.S. Trade Environment

With new tariffs in effect for 2025, the stem cell industry is realigning supply and procurement strategies. Rising duties on specialized reagents and consumables are prompting companies to explore vertical integration and seek domestic alternatives, mitigating exposure to external cost pressures. Developing regional partnerships and localized production of critical materials is also improving resilience and helping organizations manage logistics and customs complexities. These shifts encourage continued innovation in supply chain design and reagent development as companies adapt to a more unpredictable trade landscape.

Methodology & Data Sources

This report integrates a rigorous mixed-method research approach, including detailed secondary research, regulatory and patent analysis, and primary interviews with biopharma leaders, CROs, academic experts, and regulatory stakeholders. Data validation is continuous, ensuring findings accurately reflect sector developments and strategic shifts.

Why This Report Matters

  • Strategic leaders gain actionable insights to optimize clinical development, streamline operations, and identify high-value partnerships in the evolving stem cells market.
  • Comprehensive segmentation and regional analysis enable data-driven resource allocation, technology investment, and market entry planning aligned to current trends.
  • In-depth tariff and regulatory perspectives help anticipate policy impacts and sharpen competitive positioning for sustainable advantage.

Conclusion

The stem cells market is at a pivotal phase of accelerating innovation and shifting global dynamics. Senior stakeholders who embrace technology, adapt strategies for regulatory and trade developments, and prioritize collaborative growth will drive future success in this expanding field.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in induced pluripotent stem cells for personalized disease modeling and high throughput drug screening
5.2. Bioprinting of functional tissues using scaffold free stem cell spheroids for complex organ regeneration
5.3. Rapid development of allogeneic mesenchymal stem cell therapies targeting inflammatory bowel disease symptoms
5.4. Emergence of CRISPR edited hematopoietic stem cell therapies for treatment of sickle cell disease complications
5.5. First regulatory clearances for allogeneic neural stem cell implants in spinal cord injury repair protocols
5.6. Commercialization of extracellular vesicle based diagnostics derived from stem cell secretome for early disease detection
5.7. Strategic partnerships between biotech innovators and pharmaceutical companies to accelerate stem cell heart failure treatments
5.8. Investment trends in automated stem cell manufacturing platforms to scale production and reduce therapy costs
5.9. Integration of artificial intelligence driven predictive differentiation models for quality control in stem cell production
5.10. Development of off the shelf CAR T cell therapies derived from induced pluripotent stem cells for cancer treatment
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Stem Cells Market, by Cell Type
8.1. Introduction
8.2. Adult Stem Cells
8.3. Human Embryonic Stem Cells
8.4. Induced Pluripotent Stem Cells
9. Stem Cells Market, by Cell Source
9.1. Introduction
9.2. Allogeneic
9.3. Autologous
10. Stem Cells Market, by Technology
10.1. Introduction
10.2. Bioprinting
10.3. Cell Culture
10.3.1. 2D Culture
10.3.2. 3D Culture
10.4. Gene Editing
10.4.1. CRISPR
10.4.2. Transcription Activator-Like Effector Nuclease
11. Stem Cells Market, by Cell Source
11.1. Introduction
11.2. Adipose Tissue
11.3. Amniotic Cells
11.4. Bone Marrow
11.5. Peripheral Blood
11.6. Umbilical Cord
12. Stem Cells Market, by Application
12.1. Introduction
12.2. Cell Banking
12.2.1. Private Banking
12.2.2. Public Banking
12.3. Drug Discovery & Testing
12.3.1. Pharmaceutical Screening
12.3.2. Toxicity Testing
12.4. Regenerative Medicine
12.4.1. Cardiovascular
12.4.2. Neurology
12.4.3. Orthopaedics
12.5. Research & Development
13. Stem Cells Market, by End User
13.1. Introduction
13.2. Biopharmaceutical Companies
13.3. Contract Research Organizations
13.4. Hospitals & Clinics
13.5. Research Institutes
14. Americas Stem Cells Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Stem Cells Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Stem Cells Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Danaher Corporation
17.3.2. Charles River Laboratories International, Inc.
17.3.3. Advanced Cell Technology, Inc.
17.3.4. AlloSource, Inc.
17.3.5. Anterogen Co., Ltd.
17.3.6. Athersys Inc.
17.3.7. Becton, Dickinson and Company
17.3.8. Bioheart Inc.
17.3.9. Biorestorative Therapies Inc.
17.3.10. BrainStorm Cell Therapeutics Inc.
17.3.11. Bristol-Myers Squibb Company
17.3.12. Cellartis AB
17.3.13. Cellular Engineering Technologies Inc.
17.3.14. Gamida Cell Ltd
17.3.15. GE HealthCare by General Electric Company
17.3.16. GenScript Biotech Corporation
17.3.17. Gilead Sciences, Inc.
17.3.18. HOLOSTEM S.r.l. by Chiesi Farmaceutici S.p.A
17.3.19. JCR Pharmaceuticals Co., Ltd.
17.3.20. Lineage Cell Therapeutics, Inc.
17.3.21. Lonza Group
17.3.22. Merck KGaA
17.3.23. Novartis AG
17.3.24. Novo Holdings A/S
17.3.25. NuVasive Inc.
17.3.26. Pluristyx, Inc.
17.3.27. Sartorius AG
17.3.28. STEMCELL Group of Companies
17.3.29. Takeda Pharmaceutical Company Limited
17.3.30. Thermo Fisher Scientific Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL STEM CELLS MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. STEM CELLS MARKET: RESEARCHAI
FIGURE 28. STEM CELLS MARKET: RESEARCHSTATISTICS
FIGURE 29. STEM CELLS MARKET: RESEARCHCONTACTS
FIGURE 30. STEM CELLS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL STEM CELLS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY BIOPRINTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL STEM CELLS MARKET SIZE, BY BIOPRINTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL STEM CELLS MARKET SIZE, BY 2D CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL STEM CELLS MARKET SIZE, BY 2D CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL STEM CELLS MARKET SIZE, BY 3D CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL STEM CELLS MARKET SIZE, BY 3D CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL STEM CELLS MARKET SIZE, BY CRISPR, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL STEM CELLS MARKET SIZE, BY CRISPR, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL STEM CELLS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL STEM CELLS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL STEM CELLS MARKET SIZE, BY AMNIOTIC CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL STEM CELLS MARKET SIZE, BY AMNIOTIC CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL STEM CELLS MARKET SIZE, BY PRIVATE BANKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL STEM CELLS MARKET SIZE, BY PRIVATE BANKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL STEM CELLS MARKET SIZE, BY PUBLIC BANKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL STEM CELLS MARKET SIZE, BY PUBLIC BANKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL STEM CELLS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL STEM CELLS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL STEM CELLS MARKET SIZE, BY ORTHOPAEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL STEM CELLS MARKET SIZE, BY ORTHOPAEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 146. CANADA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 147. CANADA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. CANADA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. CANADA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 150. CANADA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 151. CANADA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 152. CANADA STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 153. CANADA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 154. CANADA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 155. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 158. CANADA STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 159. CANADA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 160. CANADA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 161. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 162. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 163. CANADA STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 174. MEXICO STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 175. MEXICO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 180. MEXICO STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 181. MEXICO STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 182. MEXICO STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 183. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. GERMANY STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 280. GERMANY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. GERMANY STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. GERMANY STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 286. GERMANY STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 287. GERMANY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 288. GERMANY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 289. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 292. GERMANY STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 293. GERMANY STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 294. GERMANY STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 295. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. GERMANY STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. FRANCE STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 300. FRANCE STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 302. FRANCE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 303. FRANCE STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. FRANCE STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. FRANCE STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 306. FRANCE STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 308. FRANCE STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 309. FRANCE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 310. FRANCE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 311. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. FRANCE STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 314. FRANCE STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 315. FRANCE STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 316. FRANCE STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 317. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 318. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 319. FRANCE STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. FRANCE STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. ITALY STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 344. ITALY STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 345. ITALY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 346. ITALY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 347. ITALY STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 348. ITALY STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 349. ITALY STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 350. ITALY STEM CELLS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 351. ITALY STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 352. ITALY STEM CELLS MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 353. ITALY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 354. ITALY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 355. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 356. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 357. ITALY STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2024 (USD MILLION)
TABLE 358. ITALY STEM CELLS MARKET SIZE, BY CELL BANKING, 2025-2030 (USD MILLION)
TABLE 359. ITALY STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2024 (USD MILLION)
TABLE 360. ITALY STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2025-2030 (USD MILLION)
TABLE 361. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 362. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 363. ITALY STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 364. ITALY STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 365. SPAIN STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 366. SPAIN STEM CELLS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 367. SPAIN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 368. SPAIN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 369. SPAIN STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 370. SPAIN STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 371. SPAIN STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILL

Samples

Loading
LOADING...

Companies Mentioned

  • Danaher Corporation
  • Charles River Laboratories International, Inc.
  • Advanced Cell Technology, Inc.
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Athersys Inc.
  • Becton, Dickinson and Company
  • Bioheart Inc.
  • Biorestorative Therapies Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Bristol-Myers Squibb Company
  • Cellartis AB
  • Cellular Engineering Technologies Inc.
  • Gamida Cell Ltd
  • GE HealthCare by General Electric Company
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • HOLOSTEM S.r.l. by Chiesi Farmaceutici S.p.A
  • JCR Pharmaceuticals Co., Ltd.
  • Lineage Cell Therapeutics, Inc.
  • Lonza Group
  • Merck KGaA
  • Novartis AG
  • Novo Holdings A/S
  • NuVasive Inc.
  • Pluristyx, Inc.
  • Sartorius AG
  • STEMCELL Group of Companies
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 15.72 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.45 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Stem Cell Assays Market by Product Type, Technology, Cell Type, Application, End User, Assay Format, Service - Global Forecast to 2030 - Product Image

Stem Cell Assays Market by Product Type, Technology, Cell Type, Application, End User, Assay Format, Service - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Stem Cell Therapy for Premature Ovarian Failure Market by Cell Type, Therapy Type, End User, Application - Global Forecast to 2030 - Product Image

Stem Cell Therapy for Premature Ovarian Failure Market by Cell Type, Therapy Type, End User, Application - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030 - Product Image

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Stem Cell Manufacturing Market Report by Product, Application, End User, and Region 2025-2033 - Product Image

Stem Cell Manufacturing Market Report by Product, Application, End User, and Region 2025-2033

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.